Filing Details
- Accession Number:
- 0001179110-16-028954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-23 17:30:46
- Reporting Period:
- 2016-08-19
- Filing Date:
- 2016-08-23
- Accepted Time:
- 2016-08-23 17:30:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1427944 | M. James Roach | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | Senior Vp, Development And Chi | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-08-19 | 416 | $12.04 | 157,147 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-08-19 | 426 | $12.04 | 156,721 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-08-22 | 249 | $12.10 | 156,472 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009.